$352.45
Value $5.12T
AAPL and HQY stock compared: price, dividend, valuation and results, from SEC filings.
$352.45
Value $5.12T
$97.31
Value $8.2B
Apple (AAPL) has a market value of $5.12T and HealthEquity (HQY) $8.2B. Over the last year, with dividends, AAPL moved +32.2% and HQY -2.9%. The P/E is 38.8 for AAPL and 34.8 for HQY. Dividend yield: AAPL 0.30%, HQY none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
AAPL$5.12T
HQY$8.2B
AAPL is 623 times HQY
Revenue, 12 months
AAPL$479B
HQY$1.4B
AAPL is 352 times HQY
Net income, 12 months
AAPL$132B
HQY$236M
AAPL is 559 times HQY
Operating margin
AAPL33.0%
HQY25.8%
7.2 points apart
ROIC
AAPL72.1%
HQY8.8%
63.3 points apart
P/E
AAPL38.8
HQY34.8
AAPL is 1.1 times HQY
Dividend yield
AAPL0.3%
HQY0.0%
0.3 points apart
5-year return
AAPL+135.2%
HQY+49.0%
86.2 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
AAPL+135.2%
HQY+49.0%
| Period | AAPLWith dividends | HQYWith dividends |
|---|---|---|
| 1 year since November 17, 2025 | +32.2%Price +31.8% | -2.9%Price -2.9% |
| 3 years since November 17, 2023 | +88.2%+23.5% a yearPrice +85.8% | +44.6%+13.1% a yearPrice +44.6% |
| 5 years since November 17, 2021 | +135.2%+18.7% a yearPrice +129.6% | +49.0%+8.3% a yearPrice +49.0% |
| 10 years since November 18, 2016 | +1,294.5%+30.1% a yearPrice +1,181.2% | +136.4%+9.0% a yearPrice +136.4% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
AAPLAppleHQYHealthEquity
| Price | $352.45 | $97.31 |
|---|---|---|
| Market value | $5.12T | $8.2B |
| Enterprise value (EV) | $5.15T | $8.9B |
| P/E | 38.8 | 34.8 |
| P/E, 5-year median | 34.2 | – |
| P/B | 45.7 | 4.1 |
| EV/EBIT | 32.6 | 25.3 |
| Free cash flow yield | 2.7% | 5.9% |
| Revenue, 12 months | $479B | $1.4B |
|---|---|---|
| Net income, 12 months | $132B | $236M |
| Free cash flow, 12 months | $136B | $488M |
| Earnings per share, 12 months | $8.98 | $2.77 |
| Revenue growth, year on year | 15.1% | 9.5% |
| Revenue growth a year, past | +5.5%over 5 years | +12.4%over 5 years |
| EPS growth a year, past | +9.9%over 5 years | +83.0%over 5 years |
| Gross margin | 48.8% | 71.3% |
|---|---|---|
| Operating margin | 33.0% | 25.8% |
| Net margin | 27.6% | 17.4% |
| ROIC | 72.1% | 8.8% |
| ROE | 135.4% | 11.3% |
| Cash | $56.7B | $256M |
|---|---|---|
| Total debt | $94.5B | $971M |
| Net debt / EBITDA | 0.1 | 1.3 |
| Interest cover | – | 6.7× |
| Dividend yield | 0.3% | – |
|---|---|---|
| Dividend per share, 12 months | $1.07 | – |
| Dividend growth a year, past | +4.5%over 5 years | – |
| Buyback yield | 1.7% | 3.6% |
| Shareholder yield | 2.0% | 3.6% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Apple ($5.12T) is about 623.1 times HealthEquity ($8.2B), at today's prices.
Since November 18, 2016, AAPL's price moved +1,181.2% and HQY's +136.4%. With dividends: AAPL +1,294.5% (+30.1% a year), HQY +136.4% (+9.0% a year). Past returns do not predict future ones.
The dividend yield at today's price is 0.30% for Apple and none for HealthEquity. Over the last twelve months they paid $1.07 and – per share.
At today's price, the P/E is 38.8 for AAPL and 34.8 for HQY. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 27.6% for Apple and 17.4% for HealthEquity, and the operating margin 33.0% and 25.8%. Revenue was $479B and $1.4B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.